StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 12/3068% below fair value
$5.69+0.07 (+1.25%)

Close on Nov 13, 2026Market cap $151.00MP/E –Yield –

Inogen Inc grew revenue 13.7% to $379.32M over the twelve months to Sep 30, 2026. Free cash flow was -$11.33M. At the latest close the market valued the company at $151.00M.

Revenue
$379.32M
+13.7% vs. a year earlier
Operating income
-$41.77M
TTM Q3 2026
Free cash flow
-$11.33M
TTM Q3 2026
EPS, diluted
-$1.31
TTM Q3 2026

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$151.00M
P/E ratio
–
Price to sales
0.40
Price to book
0.96
Dividend yield
–
Free cash flow yield
-7.50%

Fundamentals

Revenue
$379.32M
Net income
-$35.46M
EPS, diluted
-$1.31
Free cash flow
-$11.33M
Book value per share
$5.93
Diluted shares
26M

Trading

Next earnings
Feb 23, 2027 (estimated, during market hours)
Previous close
$5.62
Open
$5.60
Day's range
$5.55 – $5.71
Volume
238,180
Average volume (20 days)
300,913
Index membership
Russell 2000, Russell 3000
Beta (5 years)
1.25
52-week range
$5.04 – $7.67
RSI (14 days)
36.6
Volatility (1 year)
45.5%
Relative volume
0.82×
WACC
11.3%

On 1 of our idea list: More cash than they're worth

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2014, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodINGNS&P 500DifferenceINGN per yearS&P 500 per year
1 month-10.3%-3.0%−7.2 pts
3 months-2.1%-2.8%+0.7 pts
Year to date-15.3%+11.5%−26.8 pts
1 year-17.3%+13.5%−30.8 pts
3 years+17.1%+77.7%−60.6 pts+5.4%+21.1%
5 years-83.2%+72.6%−155.8 pts-30.0%+11.5%
10 years-91.1%+308.2%−399.2 pts-21.4%+15.1%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$379.32M+13.7% YoY

Gross profit

$167.15M+11.3% YoY

Operating income

-$41.77M

Net income

-$35.46M

EPS, diluted

-$1.31

Free cash flow

-$11.33M
Reported periodTrailing twelve months

Press releases

Releases Inogen filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Inogen

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Inogen, Inc. is a medical technology company that develops, manufactures, and distributes respiratory health products. Its core offerings include portable oxygen concentrators such as the Inogen One and Inogen Rove systems, designed to deliver supplemental long-term oxygen therapy while allowing patient mobility. The company also distributes stationary oxygen concentrators, CPAP masks for obstructive sleep apnea, and the Simeox airway clearance device for mucus management. Inogen serves patients with chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis, and bronchiectasis. The business delivers products directly to patients through direct-to-consumer sales and rentals, while also supplying home medical equipment providers, distributors, resellers, and clinical facilities.

Company profile, executives and history

Inogen stock: common questions

What is Inogen's stock price?

INGN closed at $5.69 on Nov 13, 2026, up 1.25% on the day. Over the past 52 weeks it traded between $5.04 and $7.67.

What is Inogen's market cap?

Inogen was worth $151.00M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.

What is INGN's P/E ratio?

Inogen lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.31), so it has no meaningful P/E ratio.

How much revenue does Inogen make?

Inogen reported revenue of $379.32M for the twelve months to Sep 30, 2026, up 13.7% from a year earlier.

Does Inogen pay a dividend?

No. Inogen has not paid a cash dividend over the last twelve months.

When does Inogen report earnings next?

Inogen is expected to report Q4 FY2026 results on Feb 23, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has INGN stock performed over the past year?

Including dividends, INGN returned -17.3% over the past year, against +13.5% for the S&P 500.

How many INGN shares are sold short?

1M shares were sold short at the latest FINRA report, 5.49% of the float, or 5.8 days of average trading volume.

Who are Inogen's competitors?

Companies most similar to Inogen by business, industry and size include TCMD, ESTA, ENOV, LAKE, INMD.

See a number that looks wrong?